Cargando…
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment
BACKGROUND: The elderly, defined here as subjects aged ≥ 65 years, are among at-risk subjects for whom annual influenza vaccination is recommended. For the 2018/19 season, three vaccine types are available for the elderly in Italy: trivalent inactivated vaccine (TIV), adjuvanted TIV (aTIV) and quadr...
Autores principales: | de Waure, Chiara, Boccalini, Sara, Bonanni, Paolo, Amicizia, Daniela, Poscia, Andrea, Bechini, Angela, Barbieri, Marco, Capri, Stefano, Specchia, Maria Lucia, Di Pietro, Maria Luisa, Arata, Lucia, Cacciatore, Pasquale, Panatto, Doanatella, Gasparini, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761839/ https://www.ncbi.nlm.nih.gov/pubmed/30929026 http://dx.doi.org/10.1093/eurpub/ckz041 |
Ejemplares similares
-
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population
por: Capri, Stefano, et al.
Publicado: (2018) -
Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis
por: BARBIERI, M., et al.
Publicado: (2017) -
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation
por: Panatto, Donatella, et al.
Publicado: (2018) -
An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign
por: Panatto, Donatella, et al.
Publicado: (2016) -
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment
por: Calabrò, Giovanna Elisa, et al.
Publicado: (2022)